Interclean Shanghai

Integra LifeSciences featured in Forbes 2008 List of 200 Best Small Companies

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

EU Begins Revision of Medical Device...

The European Commission has gone on to initiate a...

FDA Seeks Opinion on AI-Enabled Medical...

The U.S. Food and Drug Administration (US FDA) is...

FDA Approves Zenix Monitor-Defibrillator from ZOLL

ZOLL®, which happens to be an Asahi Kasei company...

MHRA in the UK Accelerates AI...

The Medicines and Healthcare Products Regulatory Agency (MHRA) from...
Integra LifeSciences Holdings Corporation , a world leader in regenerative medicine, announced that it has made Forbes magazine's 2008 list of "200 Best Small Companies."

The Forbes 200 Best Small Companies ranking is limited to companies with sales between $5 million and $750 million and a stock price of $5 as of September 29, 2008. A company's ranking is based on return on equity, sales growth, and profit growth over the past 12 months and over five years. Forbes also compares a company's stock performance with that of its industry peers.

Stuart Essig, Integra's President and CEO and CEO says, We're very pleased to have been named to Forbes 200 Best Small Companies.  Since Integra's inception in 1989, Integra has grown from a company with one product – an artificial skin, used in wound and burn care, called Integra(R) Dermal Regeneration Template – to a company with thousands of medical devices and instruments. Today, our company is a market leader in neurosurgery, we've embarked on a similar course in the hand, foot and ankle sector of the orthopedics market, and we've recently entered the spine market.

Latest stories

Related stories

EU Begins Revision of Medical Device Regulatory Framework

The European Commission has gone on to initiate a...

FDA Seeks Opinion on AI-Enabled Medical Devices Regulation

The U.S. Food and Drug Administration (US FDA) is...

FDA Approves Zenix Monitor-Defibrillator from ZOLL

ZOLL®, which happens to be an Asahi Kasei company...

MHRA in the UK Accelerates AI Rollout in the NHS

The Medicines and Healthcare Products Regulatory Agency (MHRA) from...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Translate »